Cite
A Case Report on Reversible Toxic Optic Neuropathy on Long Term Treatment of Linezolid in Extensively Drug-Resistant Tuberculosis Patient
MLA
Ashish Shah, et al. “A Case Report on Reversible Toxic Optic Neuropathy on Long Term Treatment of Linezolid in Extensively Drug-Resistant Tuberculosis Patient.” Journal of Pharmaceutical Research International, July 2021, pp. 7–11. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........a876d3ce94846a7bee9869db941666ce&authtype=sso&custid=ns315887.
APA
Ashish Shah, Rajesh Hadia, Sunil Kardani, Dhaval Joshi, Rajesh A Maheshwari, Ghanshyam Parmar, Trupal Rathod, & Avinash K. Seth. (2021). A Case Report on Reversible Toxic Optic Neuropathy on Long Term Treatment of Linezolid in Extensively Drug-Resistant Tuberculosis Patient. Journal of Pharmaceutical Research International, 7–11.
Chicago
Ashish Shah, Rajesh Hadia, Sunil Kardani, Dhaval Joshi, Rajesh A Maheshwari, Ghanshyam Parmar, Trupal Rathod, and Avinash K. Seth. 2021. “A Case Report on Reversible Toxic Optic Neuropathy on Long Term Treatment of Linezolid in Extensively Drug-Resistant Tuberculosis Patient.” Journal of Pharmaceutical Research International, July, 7–11. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........a876d3ce94846a7bee9869db941666ce&authtype=sso&custid=ns315887.